Barclays PLC : Very little upside potential, so the risk for a correction is significant
| Entry price | Target | Stop-loss | Potential |
|---|
|
GBX 168.1 |
GBX 156.6 |
GBX 174.5 |
+6.84% |
|---|
Barclays PLC shares trade close to a major resistance zone that is situated around 171.6 GBp. This zone should be difficult to break through, which in turn suggests a corrective move ahead.
Strengths● The company returns high margins, thereby supporting business profitability.
● The company's attractive earnings multiples are brought to light by a P/E ratio at 12.06 for the current year.
● This company will be of major interest to investors in search of a high dividend stock.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
● The tendency within the weekly time frame is positive above the technical support level at 152.19 GBp
● Stock prices approach a strong long-term resistance in weekly data at GBp 171.54.
● According to forecast, a sluggish sales growth is expected for the next fiscal years.
● The company's earnings releases usually do not meet expectations.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● For the past year, analysts have significantly revised downwards their profit estimates.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
